今日盘中，九源基因（02566）股价大涨5.63%，引发市场关注。该公司昨日发布的2025年中期业绩报告显示，尽管整体收入和利润有所下滑，但骨科领域产品表现亮眼，销量同比增长超过10%。
根据九源基因发布的财报，截至2025年6月30日的6个月内，公司实现收益人民币6.39亿元，同比下降9.05%；母公司股东应占纯利为9017.4万元，同比下降14.4%。虽然整体业绩出现小幅下滑，但公司骨科领域产品销量同比增长超过10%，医院渗透率持续提升，这一亮点显著提振了投资者信心。
分析人士指出，尽管九源基因上半年收入和利润有所下降，但骨科产品的强劲增长显示出公司在核心业务领域仍保持竞争力。公司表示，将围绕全年经营目标，实施差异化商业政策，以稳定现有市场和培育增量市场为重点，争取实现全年业务收入的平稳增长。市场对九源基因未来发展前景保持乐观态度，推动股价大幅上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.